Parallax Volatility Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Parallax Volatility Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,273	Closed	-$232K	–	3639
2021 Q4	$301K	Sell	8,273 -57,591	-87%	-$2.02M	﹤0.01%	2337
2021 Q3	$1.13M	Sell	65,864 -178,415	-73%	-$2.78M	﹤0.01%	1929
2021 Q2	$3.27M	Buy	+244,279	New	+$6.02M	﹤0.01%	1443
2018 Q1	–	Sell	-3,738	Closed	-$22K	–	4732
2017 Q4	$22K	Buy	+3,738	New	+$25.6K	﹤0.01%	3648
2016 Q2	–	Sell	-60,557	Closed	-$151K	–	3792
2016 Q1	$151K	Hold	60,557	–	–	﹤0.01%	1851
2015 Q4	$491K	Buy	+60,557	New	+$429K	﹤0.01%	1554

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Parallax Volatility Advisers's CCXI Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 8,273 shares — an estimated $232K sold.

Parallax Volatility Advisers first reported a position in CCXI in Q4 2015 and held it in 6 quarters. The position peaked at $3.27M in Q2 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

Parallax Volatility Advisers reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
Parallax Volatility Advisers sold 8,273 ChemoCentryx, Inc. shares in Q1 2022, an estimated $232K.
Parallax Volatility Advisers first reported a position in ChemoCentryx, Inc. in Q4 2015 and held it in 6 quarters.
Parallax Volatility Advisers's ChemoCentryx, Inc. position peaked at $3.27M in Q2 2021.
176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.